Evidence-based clinical review C. difficile in 2026: Are We Finally Preventing Recurrence More Effectively? Fidaxomicin, microbiota restoration, and risk-stratified care have changed the recurrence conversation, but access and evidence gaps still matter. Estimated reading time: 16 minutes
Tag: microbiome therapy
The Microbiome in Dermatology: Hype, Hope, or Future Standard of Care?
The Microbiome in Dermatology: Hype, Hope, or Future Standard of Care? Review Abstract The human skin microbiome has emerged as a critical factor in dermatological health and disease. This paper examines the current state of microbiome research in dermatology, evaluating whether the field represents scientific
